Global Proteomics Market Analysis
Proteomics-Market-Size
Proteomics-Market-Size
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Industry <strong>Analysis</strong><br />
<strong>Global</strong> Industry Overview<br />
• Proteomic research inherently requires huge capital investments and<br />
historically, it has yielded poor revenues. Pharmaceutical companies have<br />
hesitated in adopting the proteomics technologies in their drug<br />
development pipeline as they have been wary of premium pricing.<br />
• However, today public funding institutions are giving importance to this<br />
growing biological discipline next to comparative genomics. The proteomics<br />
market is considered an emerging area with immense potential. In fact,<br />
Governments and federal ministries in three major European countries,<br />
namely the United Kingdom, France and Germany, have allocated thematic<br />
priorities to nurture the growth of this market. This has resulted in greater<br />
industrialization of this field, which in turn, has boosted the confidence of<br />
companies to invest in this fast-paced and dynamic arena. Low return on<br />
investment that can dissuade potential entrants in proteomics technology<br />
markets has thus been offset by increasing public funding.<br />
• The increasing relevance of protein-protein interactions and protein<br />
analytics in drug discovery as well as clinical diagnostics has highlighted<br />
the importance of proteome research. Technological advancements in<br />
protein separation technologies and two-dimensional gel electrophoresis<br />
are likely to usher in a ubiquitous approach to assess differential protein<br />
expressions. Maximum utility of expression proteomics tools in the target<br />
discovery phase of drug development is likely to trigger reliable separation<br />
and identification of low abundant proteins with poor expression levels.<br />
Moreover, the development of matrix-assisted laser desorption/ionization<br />
(MALDI) and electrospray ionization (ESI) technologies has enlarged the<br />
scope of building versatile mass spectrometers, considered the cornerstone<br />
of proteomics. The improved mass spectrometers are likely to have<br />
enhanced functionalities of automation and compatibility with other<br />
proteomics equipment.<br />
www.merkleandsears.com<br />
<strong>Global</strong> proteomics market<br />
$ Million<br />
2014 2015 2016 2017 2018 2019 2020<br />
<strong>Market</strong> share breakdown, 2015<br />
xx%<br />
xx%<br />
xx%<br />
7